Supha Pharmachem (BOM:539561) ROCE %: 40.40% (As of Sep. 2025)


BOM:539561 Supha Pharmachem Ltd BOM:539561
58 GF Score
Price ₹0.32
GF Value ₹1.53
Valuation Possible Value Trap
! 12 Warning Signs
View Full Analysis

What is Supha Pharmachem ROCE %?

Supha Pharmachem BOM:539561 +3.23% 58 ROCE % is 40.40% as of Sep. 2025. GuruFocus rates BOM:539561 with a GF Score™ of 58/100 and a GF Value™ of ₹1.53 (Possible Value Trap). The stock has 12 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Supha Pharmachem's annualized ROCE % for the quarter that ended in Sep. 2025 was 40.40%.

Supha Pharmachem  (BOM:539561) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Supha Pharmachem ROCE % Related Terms

Supha Pharmachem ROCE % Historical Data

* Premium members only.

The historical data trend for Supha Pharmachem's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supha Pharmachem ROCE % Chart

Supha Pharmachem Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.34 17.64 97.60 204.34 27.64

Supha Pharmachem Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.93 16.93 22.99 17.05 40.40
BOM:539561
58GF Score
Supha Pharmachem Ltd BOM:539561
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supha Pharmachem ROCE % Calculation

Supha Pharmachem's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=120.021/( ( (19479.236 - 19049.658) + (17203.49 - 16764.58) )/ 2 )
=120.021/( (429.578+438.91)/ 2 )
=120.021/434.244
=27.64 %

Supha Pharmachem's ROCE % of for the quarter that ended in Sep. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=424.964/( ( (0 - 0) + (16231.81 - 15179.823) )/ 1 )
=424.964/( ( 0 + 1051.987 )/ 1 )
=424.964/1051.987
=40.40 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 40.40% mean?
Supha Pharmachem (BOM:539561) has a ROCE % of 40.40% as of Sep. 2025.
Is Supha Pharmachem's ROCE % too high?
Supha Pharmachem's current ROCE % is 40.40%. The Drug Manufacturers industry median ROCE % is 7.03. Supha Pharmachem's value of 40.40% is 474.7% above this industry median. Overall, Supha Pharmachem has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Supha Pharmachem's ROCE % compare to ZTS and UTHR?
Supha Pharmachem's ROCE % of 40.40% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Supha Pharmachem's value of 40.40% is 474.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Supha Pharmachem's current ROCE % of 40.40% is 474.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Supha Pharmachem's current ROCE % is 40.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supha Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Supha Pharmachem (BOM:539561) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1.53, compared to a current price of ₹0.32 — trading 79.1% below its estimated fair value. The current ROCE % is 40.40% and 474.7% above the Drug Manufacturers industry median of 7.03. Supha Pharmachem's overall GF Score™ is 58/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Supha Pharmachem (BOM:539561), the current ROCE % is 40.40% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supha Pharmachem (BOM:539561) Overvalued in 2026?

Based on GuruFocus' analysis, Supha Pharmachem stock appears to be undervalued. The current stock price of ₹0.32 is trading 79.1% below its estimated GF Value™ of ₹1.53. GuruFocus considers Supha Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:539561:

  • ROCE %: 40.40%
  • GF Value™: ₹1.53 vs. price of ₹0.32 (79.1% below fair value)
  • GF Score™: 58/100 with 12 warning signs
  • Industry Position: 474.7% above the Drug Manufacturers median

No single metric tells the full story. See the BOM:539561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Supha Pharmachem Business Description

Address Saugbaug Road, Office No. 9, Behind Ravi Vihar Hotel, K Raheja Prime, Marol Industrial Estate, Andheri (East), Mumbai, MH, IND, 400059
Supha Pharmachem Ltd, formerly known as Remedium Lifecare Ltd, is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).
58GF Score

Get the complete analysis for BOM:539561

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.32
Price
₹1.53
GF Value